| Term 
 
        | Strep. pyogenes (Virulence factors)(10) |  | Definition 
 
        | Protein F: mediates cell attachment M Protein: prevents phagocytosis
 Lipoteichoic acid: attachment
 Enzymes:
 -Streptolysin O: ASO antibodies
 -Streptolysin S: beta hemolysis
 -Streptokinase: spread
 -DNase: spread
 -Hyaluronic acid: Capsule
 -C5a peptidase: disrupt inflammation
 Streptococcal pyogenic enzymes (SPE)
 |  | 
        |  | 
        
        | Term 
 
        | Strep. pyogenes (Spectrum of diseases) (9) |  | Definition 
 
        | Pharyngitis, Impetigo, Erysipelas, Necrotizing faciitis: caused by SPE, Toxic shock syndrome: caused by SPE, Bacteremia, Rheumatic fever, Scarlet fever, Cellulitis |  | 
        |  | 
        
        | Term 
 
        | Strep. pyogenes (Treatment)(3) |  | Definition 
 
        | Penicillin, 3rd gen. cephlasporins, Vancomycin* |  | 
        |  | 
        
        | Term 
 
        | Strep. agalactiae (Virulence factors) (1) |  | Definition 
 
        | C antigen, capsule interferes w/phagocytosis |  | 
        |  | 
        
        | Term 
 
        | Strep. agalactiae (Spectrum of diseases) (8) |  | Definition 
 
        | Bacteremia, Pneumonia, Meningitis, Bone/Joint infections, Skin and soft tissue infection, Urinary infection, Wound infection, Postpardum Endometritis* |  | 
        |  | 
        
        | Term 
 
        | Strep. agalactiae (Treatment) (3) |  | Definition 
 
        | Penicillin, 3rd gen. cephlasporins, Vancomycin* |  | 
        |  | 
        
        | Term 
 
        | Groups C, F, and G (Virulence factors) Strep. anginosus
 constellatus
 intermedius
 |  | Definition 
 
        | None identified *ALPHA hemolytic
 |  | 
        |  | 
        
        | Term 
 
        | Groups C, F, and G (Spectrum of diseases) Strep. anginosus
 constellatus
 intermedius
 |  | Definition 
 
        | Similar to pyogenes and agalactiae |  | 
        |  | 
        
        | Term 
 
        | Groups C, F, and G (Treatment) Strep. anginosus
 constellatus
 intermedius
 |  | Definition 
 
        | Penicillin, 3rd gen. cephlasporins, Vancomycin* |  | 
        |  | 
        
        | Term 
 
        | Strep. pneumoniae (Virulence factors) (7) |  | Definition 
 
        | Polysaccharide capsule: evades phagocytosis Surface adhesins
 F antigen
 Phosphocholine: regs. cell wall hydrolysis
 Secretory IgA protease: destroys IgA
 Pneumolysin: invasion
 Hydrogen peroxide
 |  | 
        |  | 
        
        | Term 
 
        | Strep. pneumoniae (Spectrum of diseases) (5) |  | Definition 
 
        | Pneumonia, Sinusitis, Otitus media, Meningitis, Bacteremia |  | 
        |  | 
        
        | Term 
 
        | Strep. pneumoniae (Treatment)(3) |  | Definition 
 
        | Penicillin, 3rd gen. cephlasporins, Vancomycin* |  | 
        |  | 
        
        | Term 
 
        | Strep. viridans (Virulence facotors) |  | Definition 
 
        | none mentioned ALPHA hemolytic*
 |  | 
        |  | 
        
        | Term 
 
        | Strep. viridans (Spectrum of diseases) (4) |  | Definition 
 
        | Endocarditis, Bacteremia, Brain abcess, Oropharynx |  | 
        |  | 
        
        | Term 
 
        | Strep. viridans (Treatment) (3) |  | Definition 
 
        | Penicillin, 3rd gen. cephlasporins, Vancomycin* |  | 
        |  | 
        
        | Term 
 
        | Enterococci sp. (Virulence factors) (3) -E. facium
 -E. faecalis
 |  | Definition 
 
        | Adhesins -Cytolysin: hemolytic activity
 -Gelatinase: protection
 Inherent resistance
 |  | 
        |  | 
        
        | Term 
 
        | Enterococci sp. (Spectrum of diseases) (6) -E. facium
 -E. faecalis
 |  | Definition 
 
        | Endocarditis, GI infections, Genitourinary infections: UTI and Peritonitis, Bacteremia |  | 
        |  | 
        
        | Term 
 
        | Enterococci sp. (Treatment) (6) -E. facium
 -E. faecalis
 |  | Definition 
 
        | Ampicillin, Vancomycin, Linezdid, Daptomycin, Quinupristin/Dalfopristin, Gentamicin |  | 
        |  | 
        
        | Term 
 
        | Staphylococcus sp. (virulence factor) (many!!!) |  | Definition 
 
        | Protein A: inhibits clearance by antibody 5 Cytolytic toxins:
 Alpha: smooth muscle, many others
 Beta: phospholipids
 *Specific for sphingomyelin and                                           lipophosphotidylcholine*
 Delta: wide cytolytic activity
 Gamma/PVL: 6 toxins for CA-MRSA
 Exfoliative Toxins:
 A (ETA): heat stable; chromosomal
 B (ETB): heat labile; plasmid
 Serine proteases
 Enterotoxins:
 A: food poisoning
 B: entercolitis
 C/D: milk products
 Toxic shock syndrome toxin (TSST-1)
 Enzymes:
 Coagulase: fibrin
 Fibrinolysin: staphylokinase
 Hylauronidase: connective tissue
 Lipase: lipids
 Nuclease: DNA
 |  | 
        |  | 
        
        | Term 
 
        | Staph. aureus (Spectrum of Diseases) (13) Catalase + |  | Definition 
 
        | Staph Scalded Skin Syndrome (SSSS) *Mostly in neonates
 Food poisoning
 Toxic Shock Syndrome
 *Due to tampon use
 Pneumonia
 Skin Infections:
 Folliculitis (hair follicle)
 Farbuncles (boils)
 Carbuncles (deep farbuncle)
 Impetigo
 Erysipleas (lymphatic)
 Septic Arthritis (knee)
 Osteomylitis (bone)
 Cellulitis
 Bacteremia (anywhere in body)
 |  | 
        |  | 
        
        | Term 
 
        | Staphylococcus (Treatment) (many!!!) |  | Definition 
 
        | Methicillin Susceptible: Penicillinase resistance penicillin
 *Naficillin
 *Oxacillin
 *Cloxacillin
 *Dicloxacillin
 
 HA-MRSA:
 Vancomycin
 *Linezolid
 *Daptomycin
 *Quinupristin
 *Dalfopristin
 
 CA-MRSA:
 If hospitalized
 *Vancomycin
 If out-patient
 *TMP/SMX
 *Clindamycin
 *Doxycycline
 
 Severe infection:
 Gentamicin + Vancomycin
 |  | 
        |  | 
        
        | Term 
 
        | Staph. epidermidis (Spectrum of diseases) haemolyticus
 lugdunensis
 saprophyticus
 |  | Definition 
 
        | Cause similar infections on foreign materials in the body: Catheters
 Shunts
 Prosthetic joints
 Prosthetic heart valves
 
 S. epidermidis and S. lugdunensis cause endocarditis from prosthetic heart valves
 
 S. saprophyticus causes urinary tract infections
 |  | 
        |  | 
        
        | Term 
 
        | Neisseria gonorrhoeae (Virulence factors) (many!!!) |  | Definition 
 
        | Non-motile No spores
 Capsule-like negative charge
 NOT a capsule
 Pili: attachment; inhibits phagocytosis
 Porin proteins
 PorA
 PorB: inhib. phagosome-lysosome fusion
 Opa protein: cell-to-cell signaling
 No opa= disseminated or pelvic inflamm.
 RMP protein
 Transferrin receptor: competes with  host for iron
 Lipooligiosaccharide (LOS)
 Similar to LPS, but no O-side chain
 Still has lipid A  endotoxin
 Enzymes:
 IgA protease: cleaves IgA-1
 Vaginal and urethral infections
 β-lactamase
 
 Strictly human pathogens
 Attach to host cells by pili
 Engulfed by cells of vagina and cervix
 Infect the Fallopian tubes by endocytosis
 LOS stimulates TNF-α
 Inflammatory responsetissue damage
 IgG stimulates C5a production
 C5a is chemotactic for neutrophils
 |  | 
        |  | 
        
        | Term 
 
        | Neisseria gonorrhoeae (Spectrum of Diseases) (many!!!) |  | Definition 
 
        | Acute anterior urethritis (males) Dysuria and urethral discharge
 
 Infection of  endocervical canal (females)
 Discharge, dysuria, bleeding, pain
 
 Rectal: proctitis, anal discharge, bleeding
 Pharyngeal: usually asymptomatic
 
 Disseminated disease: rash, septic arthritis, and tenosynovitis
 
 Pelvic inflammatory disease (Opa)
 Endometritis, salpingitis, peritonitis
 Salpingitis leads to infertility
 
 Ophthalmia Neonatorum: ocular infection of newborns during passage
 |  | 
        |  | 
        
        | Term 
 
        | Neissera gonorrhoeae (Treatment) (many!!!) |  | Definition 
 
        | Diagnosis: Gram stain
 Culture on app. Media
 Antigen detection
 Nucleic Acid Test
 
 Treatment:
 For uncomplicated:
 Ceftriaxone
 Cefixime
 Disseminated:
 Ceftriaxone
 Cefotaxime
 Cefizoxime
 Spectinomycin
 For PID:
 Cephalosporin
 Clindamycin+Gentamicin
 Ceftriaxone+Doxycycline
 
 **Cannot use penicillin due to presence of β-lactamase
 |  | 
        |  | 
        
        | Term 
 
        | Neisseria meningitides (Virulence factors) |  | Definition 
 
        | Differences from N. gonorrhoeae: Has a polysaccharide capsule
 12 serogroups based on capsule
 Only uses PorA
 No β-lactamase
 
 Strictly human pathogens
 Disease occurs in absence of antibodies for the capsule
 Immunity from cross-reacting antibodies
 Avoid intracellular killing
 LOS stim. Inflammatory response
 Tissue damage
 |  | 
        |  | 
        
        | Term 
 
        | Neisseria meningitides (Spectrum of diseases) |  | Definition 
 
        | Found in oropharynx Infects when barrier is compromised
 Bacteremia
 Present with upper respiratory infection
 Meningococcemia: malaise, sepsis, rash
 Meningitis: headache, fever, cloudy spinal fluid and meningococci in spinal fluid
 Meningoencephalitis: CNS manifestations
 Cervical rigidity (Brudzinski)
 Hamstring spasm (Kernig)
 Petechiae
 Waterhouse-Friderichsen Syndrome
 (adrenal insufficiency)
 Disseminated intravascular coagulation
 Shock (LOS endotoxin)
 Skin lesions
 Meningitis is absent
 Pneumonia
 Arthritis
 Urethritis
 |  | 
        |  | 
        
        | Term 
 
        | Neisseria meningitides (Treatment) |  | Definition 
 
        | Predisposing factors include overcrowding, poor health, and poor living conditions. College dorms
 Military barricks
 
 Treatment:
 Penicillin
 Cephalosporin
 Chloramphenicol
 
 Vaccines:
 MCV-4: patients aged 2-55
 MPSV-4: patients > 55
 
 **Both vaccines contain polysaccharide capsular material from types A, C, Y, and W-135.
 |  | 
        |  | 
        
        | Term 
 
        | Eikenella corrodens (Gram neg. bacillus) |  | Definition 
 
        | Opportunistic Diseases: Endocarditis due to human bite or oral trauma, Causative agent for sinusitis, meningitis, pneumonia, and brain/lung abcesses
 Treatmant: Penicillin, cephalosporin, tetracyclines, Flouroquinolones
 |  | 
        |  | 
        
        | Term 
 
        | Kingella kingae (G neg coccobacillus) |  | Definition 
 
        | Normal flora of oropharynx Diseases: Septicarthritis, endocarditis
 Treatment: Penicillin, tetracycline, erythromycin, flouroquinolones, Aminoglycosides
 |  | 
        |  | 
        
        | Term 
 
        | Clos. tetani (terminal spore) (Virulence factors) |  | Definition 
 
        | Two exotoxins: Tetanolysin: lyses blood cells
 Heat-labile hemolysin
 Tetanospasmin: neurotoxin
 Gene on nonconjuctive plasmid
 
 Tetanospasmin prod. in stationary phase
 One of the most potent toxins known
 Toxin binds to terminal nerve ending
 Translocates across cell membrane
 Carried to CNS
 Transferred to spinal inhibitory neurons
 Suppression of inhibitory NT’s
 Unrestrained firing
 Uncontrolled muscle contractions
 |  | 
        |  | 
        
        | Term 
 
        | Clos. tetani (terminal spore) (Spectrum of diseases) |  | Definition 
 
        | Trismus (lockjaw) Risus sardonicus: facial musc contractions
 Opisthotonos: persistent back spasm
 Laryngospasm
 Neonatal tetanus
 |  | 
        |  | 
        
        | Term 
 
        | Clos. tetani (terminal spore) (Treatment) |  | Definition 
 
        | Treatment: Wound cleaning
 Supportive therapy
 Tracheostomy
 Tetanus immune globulin
 Tetanus toxoid
 Metronidazole
 
 2 Vaccines available:
 Toxoid vaccine: inact. toxin
 Anti-toxin: antibodies
 |  | 
        |  | 
        
        | Term 
 
        | Clos. botulinum (subterminal spore) (Virulence factors) |  | Definition 
 
        | Seven types of exotoxins (A-G) Specific anti-toxin required to neutralize
 Types A, B, E, and F are most prominent
 
 Exotoxin protected by non-toxic proteins
 Exotoxin is heat-labile
 Paralysis caused by blocking ACh release
 |  | 
        |  | 
        
        | Term 
 
        | Clos. botulinum (subterminal spore) (Spectrum of diseases) |  | Definition 
 
        | NOT an infection, but an INTOXICATION 
 Foodborne Botulism
 Contaminated food
 Nausea and dizziness
 Loss of cranial nerve function
 Ocular abnormalities
 Death by respiratory failure
 
 Infant Botulism    **Honey**
 Constipation, weakness, apneic episodes
 Flaccid paralysis
 Respiratory arrest
 
 Wound Botulism
 Contamination of wounds
 Toxin production in wound
 
 Inhalation botulism
 Bioterrorism
 High mortality
 |  | 
        |  | 
        
        | Term 
 
        | Clos. botulinum (subterminal spore) Treatment) |  | Definition 
 
        | Supportive Metronidazole
 Penicillin
 Trivalent Antitoxin
 A, B, and E
 |  | 
        |  | 
        
        | Term 
 
        | Clos. perfringens (no spores) (Virulence factors) |  | Definition 
 
        | Alpha toxin: it is a lecithinase Lyse RBC, WBC, platelets, endothelium
 Myonecrosis
 Hepatotoxicity
 Myocardial dysfunction
 Beta toxin:
 Intestinal stasis
 Mucosal necrosis
 Necrotizing enteritis
 Epsilon toxin:
 Protoxin that is activated by trypsin
 Increased GI permeability
 Iota toxin:
 Increases vascular permeability
 Necrotic activity
 Enterotoxin:
 Heat-labile toxin
 Causes diarrhea
 |  | 
        |  | 
        
        | Term 
 
        | Clos. perfringens (no spoores) (Spectrum of diseases) |  | Definition 
 
        | Cellulitis: Cellular destruction w/ gas formation
 Suppurative myositis:
 Pus in muscle w/ no necrosis
 Myonecrosis:
 Caused by Alpha toxin
 Muscle necrosis, shock, renal failure
 Significant gas production
 Food Poisoning:
 Watery diarrhea and cramps
 Necrotizing Entercolitis:
 Associated w/ Type C strains
 Beta toxin responsible for pathology
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 5 types of C. perfringens (A-E).
 Only Types A and C cause human disease
 
 Treatment:
 Surgery
 Penicillin
 Hyperbaric chambers
 **unproven
 |  | 
        |  | 
        
        | Term 
 
        | Clos. difficile (Virulence factors) |  | Definition 
 
        | Enterotoxin (Toxin A) Influx of neutrophils
 Increased intestinal permeability
 Cytotoxin: destructs cytoskeleton in gut
 |  | 
        |  | 
        
        | Term 
 
        | Clos. difficile (Spectrum of diseases) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clos. difficile (Treament) |  | Definition 
 
        | Discontinue offending antibiotic Oral Vancomycin
 |  | 
        |  |